Manufacture and supply cosmetic ingredients such as 1,3-Butylene glycol and polyglycerin. Now — the numbers.
This is an established company with proven profits.
Average growth of 6% a year over the last 4 years. Every year shown ended in profit.
The gap is $1.5B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 35.9× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $0.39 per share each year — regular cash for whoever holds the stock.
The company’s market value is 36 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn.
Costs swallow the gains that sales growth brings in.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.